benzyl isothiocyanate has been researched along with Malignant Melanoma in 4 studies
benzyl isothiocyanate: inhibits carcinogen-induced neoplasia; structure in Negwer, 5th ed, #715; also promotes urinary bladder carcinoma
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to determine the role of phenethyl and benzyl isothiocyanates in modulating histone acetylation and methylation as a potential epigenetic therapeutic strategy in an in vitro model of malignant melanoma." | 8.02 | Benzyl and phenethyl isothiocyanates as promising epigenetic drug compounds by modulating histone acetylation and methylation marks in malignant melanoma. ( Anestopoulos, I; Franco, R; Kyriakou, S; Mitsiogianni, M; Panayiotidis, MI; Pappa, A; Trafalis, DT, 2021) |
| " The aim of this study was to determine the role of phenethyl and benzyl isothiocyanates in modulating histone acetylation and methylation as a potential epigenetic therapeutic strategy in an in vitro model of malignant melanoma." | 4.02 | Benzyl and phenethyl isothiocyanates as promising epigenetic drug compounds by modulating histone acetylation and methylation marks in malignant melanoma. ( Anestopoulos, I; Franco, R; Kyriakou, S; Mitsiogianni, M; Panayiotidis, MI; Pappa, A; Trafalis, DT, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitsiogianni, M | 1 |
| Anestopoulos, I | 1 |
| Kyriakou, S | 1 |
| Trafalis, DT | 1 |
| Franco, R | 1 |
| Pappa, A | 1 |
| Panayiotidis, MI | 1 |
| Ma, YS | 1 |
| Hsiao, YT | 1 |
| Lin, JJ | 1 |
| Liao, CL | 1 |
| Lin, CC | 1 |
| Chung, JG | 2 |
| Sahu, RP | 1 |
| Huang, SH | 1 |
| Wu, LW | 1 |
| Huang, AC | 1 |
| Yu, CC | 1 |
| Lien, JC | 1 |
| Huang, YP | 1 |
| Yang, JS | 1 |
| Yang, JH | 1 |
| Hsiao, YP | 1 |
| Wood, WG | 1 |
| Yu, CS | 1 |
4 other studies available for benzyl isothiocyanate and Malignant Melanoma
| Article | Year |
|---|---|
Benzyl and phenethyl isothiocyanates as promising epigenetic drug compounds by modulating histone acetylation and methylation marks in malignant melanoma.
Topics: Acetylation; Cell Line, Tumor; Cell Survival; Epigenesis, Genetic; Histones; Humans; Isothiocyanates | 2021 |
Phenethyl Isothiocyanate (PEITC) and Benzyl Isothiocyanate (BITC) Inhibit Human Melanoma A375.S2 Cell Migration and Invasion by Affecting MAPK Signaling Pathway
Topics: Anticarcinogenic Agents; Apoptosis; Cell Movement; Cell Proliferation; Gene Expression Regulation, N | 2017 |
Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells.
Topics: Animals; Apoptosis; Azepines; Cell Line; Cell Proliferation; Gene Expression Regulation; Humans; Iso | 2015 |
Benzyl isothiocyanate (BITC) induces G2/M phase arrest and apoptosis in human melanoma A375.S2 cells through reactive oxygen species (ROS) and both mitochondria-dependent and death receptor-mediated multiple signaling pathways.
Topics: Apoptosis; bcl-2-Associated X Protein; Calcium; Cardiolipins; Caspase 3; CDC2 Protein Kinase; cdc25 | 2012 |